PRLD
USDPrelude Therapeutics Incorporated Common Stock
リアルタイム価格
価格チャート
主要指標
市場指標
始値
$1.190
高値
$1.280
安値
$1.173
出来高
1.13M
企業ファンダメンタルズ
時価総額
71.5M
業種
バイオテクノロジー
国
United States
取引統計
平均出来高
1.27M
取引所
NMS
通貨
USD
52週レンジ
関連ニュース
Prelude Therapeutics Announces Exclusive Option Agreement with Incyte to Advance Mutant Selective JAK2V617F JH2 Inhibitors
Incyte secures an exclusive option to acquire Prelude's mutant selective JAK2V617F JH2 inhibitor program Mutant selective JAK2V617F JH2 inhibitors have disease-modifying potential in treating patients living with
Prelude Therapeutics Announces Strategic Business Update
Prelude to prioritize development of mutant selective JAK2V617F JH2 inhibitor and KAT6A selective degrader programs Pausing further clinical development of SMARCA2 selective degrader programs JAK2V617F option agreement
Prelude Therapeutics Announces Publication of Abstracts for Presentation at the American Society of Hematology 67th Annual Meeting
WILMINGTON, Del., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (NASDAQ:PRLD) ("Prelude" or the "Company"), a clinical-stage precision oncology company, today announced the publication of two
